| Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
|---|
| 01/07/1999 | EP0888340A1 4-(benzo-1,3-dioxolyl)-pyrrolidine-3-carboxylic acid derivatives as endothelin antagonists |
| 01/07/1999 | EP0888337A1 Piperidone tachykinin antagonists |
| 01/07/1999 | EP0888336A1 Novel substituted n-methyl-n-(4-(4-(1h-benzimidazol-2-yl-amino)p iperidin-1-yl)-2-(aryl)butyl)benzamides useful for the treatment of allergic diseases |
| 01/07/1999 | EP0888335A1 Novel pyrimidine compounds useful in treating cytokine mediated diseases |
| 01/07/1999 | EP0888333A1 Novel benzothiepines having activity as inhibitors of ileal bile acid transport and taurocholate uptake |
| 01/07/1999 | EP0888329A1 NOVEL ASYMMETRIC SYNTHESIS OF R-$g(a)-PROPYL-PIPERONYL AMINE AND ITS ANALOGS |
| 01/07/1999 | EP0888327A1 Benzopyran derivatives having leukotriene-antagonistic action |
| 01/07/1999 | EP0888319A1 Substituted 1,2,3,4-tetrahydronaphthalene derivatives |
| 01/07/1999 | EP0888299A1 Sulphur derivatives with a retroamide bond as endothelin-converting enzyme inhibitors |
| 01/07/1999 | EP0888293A1 N-acylaminoalkylhydrazinecarboximidamides |
| 01/07/1999 | EP0888128A2 Delivery of exogenous compounds |
| 01/07/1999 | EP0888123A2 Antagonism of endothelin actions |
| 01/07/1999 | EP0888120A1 Hla binding peptides and their uses |
| 01/07/1999 | EP0888115A1 Iron complexes of nitrogen-containing macrocyclic ligands effective as catalysts for dismutating superoxide |
| 01/07/1999 | EP0888113A1 Use of an alkanoyl-l-carnitine for the treatment of glutamate mediated diseases |
| 01/07/1999 | EP0698040A4 Lhrh antagonists |
| 01/07/1999 | EP0639580B1 Glycosphingolipids |
| 01/07/1999 | EP0592562B1 Bmp-9 compositions |
| 01/07/1999 | EP0386117B1 Treating premenstrual or late luteal phase syndrome |
| 01/07/1999 | DE19728524A1 Cyclische Azapeptide Cyclic Azapeptide |
| 01/07/1999 | DE19728436A1 Niedrigdosierte 15-Desoxyspergualin-Präparate Low-dose 15-deoxyspergualin preparations |
| 01/07/1999 | DE19728326A1 Neue Chinoxalindionderivate, deren Herstellung und Verwendung in Arzneimitteln New quinoxalinedione derivatives, their preparation and use in medicaments |
| 01/07/1999 | DE19727117A1 Phenylalkylderivate, diese Verbindungen enthaltende Arzneimittel und Verfahren zu ihrer Herstellung Phenylalkylderivate, pharmaceutical compositions containing them and methods for their preparation |
| 01/07/1999 | CA2295925A1 Kringle domains 1-5 of plasminogen, capable of modulating angiogenesis in vivo |
| 01/07/1999 | CA2295229A1 Induction of an activated myeloid dendritic cell phenotype |
| 01/07/1999 | CA2295208A1 Calcium-binding phosphoprotein |
| 01/07/1999 | CA2295153A1 Antithrombotic agents |
| 01/07/1999 | CA2295098A1 Calcium blockers to treat proliferative vitreoretinopathy |
| 01/07/1999 | CA2294904A1 Control of acidic gut syndrome |
| 01/07/1999 | CA2294550A1 Use of phospholamban inhibitors for increasing coronary flow |
| 01/07/1999 | CA2294232A1 Carboxylic acids and derivatives thereof and pharmaceutical compositions containing them |
| 01/07/1999 | CA2293565A1 Novel n-benzenesulphonyl-l-proline compounds, preparation method and use in therapy |
| 01/07/1999 | CA2292794A1 Ace-inhibitor nitric salts |
| 01/07/1999 | CA2291734A1 Substituted 3-(benzylamino)piperidine derivatives and their use as therapeutic agents |
| 01/07/1999 | CA2291689A1 Tricyclic pyrazolo-pyridazinone analogues as gaba-a receptor ligands |
| 01/07/1999 | CA2288744A1 Phenylalkyl derivatives, pharmaceutical compositions containing these compounds and processes for preparing them |
| 01/06/1999 | CN1204341A Oligopeptide compounds containing D-2-alkyltryptophan capable of promoting release of growth hormone |
| 01/06/1999 | CN1204320A Alpha-substituted arylsulphonamido hydroxamic acids as TNF-alpha and matrix metalloproteinase inhibitors |
| 01/06/1999 | CN1041524C Oligopeptides derived from C-reactive protein fragments and its medical composition |
| 01/05/1999 | US5856574 Ortho-subsituted benzoylguanidines, process for their preparation, their use as a medicament or diagnostic, and medicament containing them |
| 01/05/1999 | US5856566 Colored particles; irradiation of crystals |
| 01/05/1999 | US5856529 Adjustment of nervous system, endocrine function; reproduction, body weight and metabolism |
| 01/05/1999 | US5856509 Hypotensive agents |
| 01/05/1999 | US5856506 (oxazolylcarbonylamino)ethylamino glutamate derivatives |
| 01/05/1999 | US5856490 Aryl or heteroaryl amides of tetrahydronaphthalene, chroman, thiochroman and 1,2,3,4-tetrahydroquinoline carboxylic acids, having an electron withdrawing substituent in the aromatic or heteroaromatic moiety, having retinoid-like biological activity |
| 01/05/1999 | US5856489 Catalytic hydrogenation |
| 01/05/1999 | US5856461 Antibody |
| 01/05/1999 | US5856449 Glycoprotein |
| 01/05/1999 | US5856448 Materials involved in the control of the cardiovascular system, and in particular to activities mediated by thrombin and its cellular receptor. |
| 01/05/1999 | US5856439 Farnesyl transferase inhibitors, preparation thereof, and pharmaceutical compositions containing same |
| 01/05/1999 | US5856435 Gene therapy; transferring nucleic acids |
| 01/05/1999 | US5856364 Mixture of pyruvate salt, antioxidant and fatty acid |
| 01/05/1999 | US5856358 Prevent bone erosion |
| 01/05/1999 | US5856356 Use of strontium salts and pharmaceutical compositions thereof for the treatment of arthrosis |
| 01/05/1999 | US5856354 Tachykinin antagonists |
| 01/05/1999 | US5856349 2-Saccharinylmethyl heterocyclic carboxylates useful as proteolytic enzyme inhibitors and compositions and method of use thereof |
| 01/05/1999 | US5856344 Sulfonylamino-substituted benzoylguanidines, a process for their preparation, their use as a medicament or diagnostic aid, and medicament containing them |
| 01/05/1999 | US5856342 Combination of a β-receptor blocker and a local anaesthetic |
| 01/05/1999 | US5856341 Benzo B! indeno 2,1-D! thiophene compounds, intermediates, processes, compositions and methods |
| 01/05/1999 | US5856338 Sulfonamide-substituted compounds, processes for their preparation, their use as a medicament or diagnostic, and pharmaceutical preparation comprising them |
| 01/05/1999 | US5856335 Substituted aminothienopyridines, pharmaceutical composition and use |
| 01/05/1999 | US5856330 Use of xanthine derivatives for the inhibition of dephosphorylation of cofilin |
| 01/05/1999 | US5856323 Compounds and methods for the treatment of disorders mediated by platelet activating factor or products of 5-lipoxygenase |
| 01/05/1999 | US5856314 Thio-substituted, Nitrogen-containing, heterocyclic phosphonate compounds, pharmaceutical compositions, and methods of treating abnormal calcium and phosphate metabolism |
| 01/05/1999 | US5856184 Isolated domains of type IV collagen to modify cell and tissue interactions |
| 01/05/1999 | US5856152 Transgenic supplying to cells |
| 01/05/1999 | US5856138 Human parathyroid hormone muteins and production thereof |
| 01/05/1999 | US5856133 G-beta-gamma regulated phosphatidylinositol-3'kinase |
| 01/05/1999 | US5856132 G-beta-gamma regulated phosphatidylinositol-3' kinase |
| 01/05/1999 | US5856129 Hydridized detector |
| 01/05/1999 | US5856121 Nucleotide sequence |
| 01/05/1999 | US5855987 Bioactive conjugates of cellulose with amino compounds |
| 01/05/1999 | US5855920 Total hormone replacement therapy |
| 01/05/1999 | CA2235103A1 New exocellular polysaccharide produced by streptococcus thermophilus |
| 01/05/1999 | CA2152919C Prodrugs of antiinflammatory 3-acyl-2-oxindole-1-carboxamides |
| 01/05/1999 | CA2044269C Cafeic acid based pharmaceutical and cosmetic depigmenting compositions |
| 01/03/1999 | CA2236462A1 Murc |
| 01/02/1999 | CA2221861A1 Ynl075w/htxft19 |
| 12/30/1998 | WO1998059040A2 Human catalytic telomerase sub-unit and its diagnostic and therapeutic use |
| 12/30/1998 | WO1998058952A1 Angiotensin derivatives |
| 12/30/1998 | WO1998058950A1 Compounds with growth hormone releasing properties |
| 12/30/1998 | WO1998058949A1 Treatment of insulin resistance with growth hormone secretagogues |
| 12/30/1998 | WO1998058947A1 Dipeptide derivatives as growth hormone secretagogues |
| 12/30/1998 | WO1998058944A1 Compositions and methods for activating genes of interest |
| 12/30/1998 | WO1998058938A1 Alkyl-4-silylheterocyclic phenols and thiophenols as antioxidant agents |
| 12/30/1998 | WO1998058934A1 Novel 2-(iminomethyl)amino-phenyl derivatives, preparation, application as medicines and compositions containing same |
| 12/30/1998 | WO1998058926A1 Fused polycyclic 2-aminopyrimidine derivatives as protein kinase inhibitors |
| 12/30/1998 | WO1998058925A1 Barbituric acid derivatives with antimetastatic and antitumor activity |
| 12/30/1998 | WO1998058922A1 Synthesis and use of retinoid compounds having negative hormone and/or antagonist activities |
| 12/30/1998 | WO1998058919A1 Angiogenesis inhibiting 5-substituted-1,2,4-thiadiazolyl derivatives |
| 12/30/1998 | WO1998058916A1 NEW β-AMINO AND β-AZIDOCARBOXYLIC ACID DERIVATIVES, THE PRODUCTION THEREOF AND THE USE THEREOF AS ENDOTHELIN RECEPTOR ANTAGONISTS |
| 12/30/1998 | WO1998058915A2 Pyrimidin-2,4,6-trion derivatives and their use as metalloprotease-inhibitors |
| 12/30/1998 | WO1998058913A1 Chalcones having antiproliferative activity |
| 12/30/1998 | WO1998058676A1 Pharmaceutical composition having enhanced antitumor activity and/or reduced side effects, containing an antitumor agent and an hydroxamic acid derivative |
| 12/30/1998 | WO1998058672A1 Cd154 blockade therapy for therapeutic protein inhibitor syndrome |
| 12/30/1998 | WO1998058646A1 Use of somatostatin agonists and antagonists for treating diseases related to the eye |
| 12/30/1998 | WO1998058639A1 Synergistically acting compositions for selectively combating tumor tissue |
| 12/30/1998 | WO1998058638A1 Method of treating heart failure |
| 12/30/1998 | WO1998058636A1 Analgesic methods using synthetic catalysts for the dismutation of superoxide radicals |
| 12/30/1998 | WO1998058633A2 Microdose therapy of vascular conditions by no donors |